Leukemia, which is particularly severe in childhood cases, is the result of genetic and environmental interaction and dysfunction of the blood forming tissues. Public health concern over benzene is warranted because it is released into the environment from both natural and industrial sources and has become ubiquitous in air, water, soil, and, subsequently, in food and beverages. Benzene is carcinogenic to both humans and laboratory rodents. At high levels of exposure (< 30 ppm) benzene is associated with depression of blood forming elements leading to anaplastic anemia, followed by myelodysplastic syndrome (MDS) and, ultimately, to leukemia. The effect of long term exposure to relatively low levels of benzene is unknown. Experimental animal models of benzene induced leukemogenesis have not been successfully developed and, thus, mechanistic studies of benzene induced leukemogenesis under defined experimental conditions are lacking. Using the genetically altered mouse line Tg.AC, which carries two copies of an inducible viral Harvey ras (v-H-ras) gene, we have been able to demonstrate the induction of both skin tumors and myeloid leukemia after dermal exposure to high levels of benzene. Further investigation has revealed that the topical application of benzene induced suppression of both erythroid (red cell) and myeloid (white cell) components is followed by development of a myeloid leukemia in the bone marrow which invade the spleen, liver, lungs, and peripheral blood. Leukemia bone marrow cells transplanted to irradiated syngeneic non-genetically altered hosts develop foci, which show a high proportion of blast-like cells that undergo differentiation to immature granulocytes, and express the inducible v-H-ras transgene. Presently, we are investigating the genetic changes associated with this transformation that occur during benzene exposure. Development of an experimental model for benzene induced leukemia in a short term bioassay may allow us to determine: (1) a mechanistic basis for leukemogenesis under these experimental conditions and the genetic factors that play a role in susceptibility and (2) strategies for intervention and prevention.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Intramural Research (Z01)
Project #
1Z01ES021134-02
Application #
6106571
Study Section
Special Emphasis Panel (LECM)
Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
1998
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Kang-Sickel, Juei-Chuan C; Stober, Vandy P; French, John E et al. (2010) Exposure to naphthalene induces naphthyl-keratin adducts in human epidermis in vitro and in vivo. Biomarkers 15:488-97
Donehower, Lawrence A; French, John E; Hursting, Stephen D (2005) The utility of genetically altered mouse models for cancer research. Mutat Res 576:1-3
MacDonald, James; French, John E; Gerson, Ronald J et al. (2004) The utility of genetically modified mouse assays for identifying human carcinogens: a basic understanding and path forward. The Alternatives to Carcinogenicity Testing Committee ILSI HESI. Toxicol Sci 77:188-94
Martin, Keith R; Jokinen, Micheal P; Honeycutt, Hayden P et al. (2004) Tumor profile of novel p53 heterozygous Tg.AC (v-Ha-ras) bitransgenic mice treated with benzo(a)pyrene and fed dietary N-acetyl-L-cysteine (NAC). Toxicol Sci 81:293-301
Martin, Keith R; Jokinen, Michael P; Honeycutt, Hayden P et al. (2004) Tumor spectrum in the p53 heterozygous zeta globin-promoted Tg.AC (v-Ha-ras) bitransgenic mouse model. Toxicol Pathol 32:418-25
French, John E (2004) Identification and characterization of potential human carcinogens using B6.129tm1Trp53 heterozygous null mice and loss of heterozygosity at the Trp53 locus. IARC Sci Publ :271-87
Nwosu, Veronica C; Kissling, Grace E; Trempus, Carol S et al. (2004) Exposure of Tg.AC transgenic mice to benzene suppresses hematopoietic progenitor cells and alters gene expression in critical signaling pathways. Toxicol Appl Pharmacol 196:37-46
Pritchard, John B; French, John E; Davis, Barbara J et al. (2003) The role of transgenic mouse models in carcinogen identification. Environ Health Perspect 111:444-54
Boley, Scott E; Wong, Victoria A; French, John E et al. (2002) p53 heterozygosity alters the mRNA expression of p53 target genes in the bone marrow in response to inhaled benzene. Toxicol Sci 66:209-15
Hulla, J E; French, J E; Dunnick, J K (2001) Chromosome 11 allelotypes reflect a mechanism of chemical carcinogenesis in heterozygous p53-deficient mice. Carcinogenesis 22:89-98

Showing the most recent 10 out of 17 publications